Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ATZ - Adelwitz Technologiezentrum GmbH is a German biotechnology company and research center specializing in the development and application of advanced in vitro cell culture systems. The company is a pioneer in Multi-Organ-Chip (MOC) technology, providing microfluidic platforms that simulate human organ functions for drug testing and toxicity screening. ATZ offers a range of services including contract research, laboratory space for startups, and the development of specialized biotechnological equipment. By providing sophisticated alternatives to animal testing, the center supports the pharmaceutical, chemical, and cosmetic industries in developing safer and more effective products. Their expertise bridges the gap between basic research and industrial application in the field of regenerative medicine and pharmacology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adelwitz Technologiezentrum.